Blood Glucose Variations and Clinical Experience with Glibenclamide in Diabetes MellitusBr Med J 1970; 2 doi: http://dx.doi.org/10.1136/bmj.2.5709.572 (Published 06 June 1970) Cite this as: Br Med J 1970;2:572
- D. J. O'Sullivan,
- W. F. Cashman
Thirty patients were treated with glibenclamide for periods up to 16 months. The drug is a potent hypoglycaemic agent, and taken in a single daily dose controls blood glucose levels over a 24-hour period in maturity onset diabetes. A definite dose-effect relationship exists, and the drug may be used in doses of 5 to 20 mg. daily. There were no appreciable side-effects or toxic effects during the period of study.